1/25/2010

ValueMyPatent.com

PatentValuationReport
U.S.IssuedPatent:7,XXX,XXX

Note:theactualpatentsnumbersandanyidentifiableinformationhasbeenremoved
andreplacedinthissamplereport.Ofcourse,yourreportwillcontainyourpatent
numberandthedetailsofclaims,citedpatents,etc.

EstimatedValue:U.S. $167,820

Copyright2011ValueMyPatent.com
 PatentU.S.7,XXX,XXX:FactsandFigures
PatentTitle:
USPTOPublication:
OriginalApplicationNumber:
Abstract:
Dates
DatePatentWasFiled:
PriorityDate:
DatePatentIssued:
YearstoExpiration(Estimated):
AgefromPriorityClaim:
AgeRelativetoPatentsinField:
MaintenanceandExpiration
ExpirationStatus:
MaintenanceStatus:
Inventor,Assignees&Individuals
Inventor(s):
Examiner:
FrontPageAssignee:
CurrentAssignee:
AssigneeLocation:
AssignmentHistory:
PatentClassification
USPatentClasses:
PatentValuationReportbyValueMyPatent.com
Loremipsumhasquidamlaoreetex,nec agamputodicamcu.Annecliber
fabellas,saleurbanitasrepudiandae
7,XXX,XXX
10/90XXXX
Loremipsumanhasdictahomerofeugait,sitidchoroponderum.Natum
solutapetentiumeupri.Odioduisaliquideteos.Quisanctusvivendo
percipitid,exullumsuavitateabhorreantduo.Eumneiudicoputant
disputationi.Quisonetsemperscriptate,deserunthendreritquoea.Sitno
primisdoctusepicurei,quisuasessedocendiet.Choromeliusponderumad
est,exmeaprimisdiscerepertinacia,advixerrormovetverterem.Vim
nostrosapientemno,atsenseritconvenirepericulissed.Anunum
eloquentiamdefinitionemnec.
22Apr200X
.
16Oct200X
14.08
5.92
0.17
8thyearfeewindowopens:10/1X/20XX
8thyearfeewindowopens:10/1X/20XX
Firstname,Lastname (Cupertino,CA)
ExaminerSmith
Unassigned
USPTO:AssignmentDataNotAvailable
Unassigned
Unassigned
4XX/X50.1;3XX/469;3XX/X74;4XX/X18;4XX/X19;7XX/XX4
Page2
 USClassDescription:
InternationalClass(es):
PatentValuationReportbyValueMyPatent.com
4XX/X50.1: Anassumdicitrectequeest,
3XX/469:Etquasnullasplendidecum,noquolaborereferrentur.
3XX/X74:Sedeadebetconceptam.
4XX/X18:Cuusuporronihillobortis.Civibuspersequerisetnam,
4XX/X19:Sitminimrecusaboex.Iddictaseirmodsed,innullamvocibus
moderatiusvis,etsummomundimei.
7XX/XX4:Seaadmodumadipiscidemocritumei,peratametubique
percipit.
HXXM1/00(200XXX01)
Page3
 EstimatedValueofPatentU.S.7,XXX,XXX

EstimatedValue(US$): $167,820

Thepricethataready,ableandwillingbuyerwouldlikelypaytoacquirethepatenttodayisestimatedtobeU.S.
7,XXX,XXX.Thevalueisdeterminedbycomparingthepatentwithsimilarpatentsthathaverecentlysoldonthe
marketplace.Thepriceofcomparablepatentsiscollectedfromthemostactivepatentbrokersandpatenttrading
exchangesinordertodeterminetheaverageprices.

Thesevaluationmetricshavebeendeterminedusingmethodologiesmirroringthoseusedbypatentbuyersactive
inthemarketplacetoday.Moreinformationonthevaluationmetricsappliedhereisavailableonthefollowing
webpage:http://www.valuemypatent.com/Methodology.aspx.

ClaimsofPatentU.S.7,XXX,XXX
WordsinShortestClaim:71

Thispatentsclaimsarestrong.Thelanguagedescribingtheclaimsisrelativelyshortandconcise.Thepatent
claimsdeterminethescopeoftherightsthepatentrepresentsitisprimarilytheclaimsthatareassertable
againstinfringers.Thecontentandconstructionoftheclaimsarekeytodeterminationofthepatent'svalue.A
patentwithshort,conciseclaimsisconsideredmorevaluablethanapatentwithlongclaims.Apatentwithboth
methodandapparatusclaimsisconsideredmorevaluablethanapatentwitheithermethodorapparatusclaims.
Apatentwithseveralclaimsisconsideredmorevaluablethanapatentwithasingleclaim.

Inthiscase,mostofthekeywordsformingtheclaimsaredefinedinthespecifications.Inordertoavoidadispute
astothemeaningofawordintheclaims,itisgoodpracticeforeachwordintheclaimtobedescribedand
definedinthespecifications.Ifeachofthekeywordsisdefined,thiswilladdsomevaluetothepatent,ifallthe
keywordsarenotdefined,thiswouldenhancethepossibilityoftheclaimmeaningbeingdisputedbyapotential
infringerandreducethevalueofthepatent.

Claim1:
ShortestClaim(ifnotclaim1):
1.Loremipsumiracundiavoluptatibussedne,excumlabiturinvidunt
electram.Cuexercivolumusdoloresper,tedelenitisimiliquepro,idduo
brutedeterruisset.Ateumaudirehabemusconcludaturque,estangraeci
laoreetaccusata,hisomniseuismodex.Duovidissevivendoex.Easonet
laboredebitisvix.Sumotemporsadipscingeosex,dicatdelicatissimipriet.
Visinnumquamhonestatispersequeris.Inmeliorephaedrumcum,cuodio
illudpropriaemei,etquodsiadversariumvel.Seaatevertidissentiet,ut
eiusdisputationieum.Anprolaudempopulo,utsitvidenatum,sea
numquamfierentpetentiumid.Eutalesensibuseum,cuneciuvaret
delectushendrerit,eudictasregionelaboramusvel.Proidquenovum
philosophiaet.Velsolethonestatisreformidansid.Aliquidurbanitasidhas,
habeodebetiudicabitvixid.Usuprimaaequeneglegenturid,nemeipaulo
audirepetentium.Vixdicatdictaspercipitut.Solutasimiliqueconstitutoad
ius.Numquamcontentionespriid,proeuripidisdefinitionemid.Alia
ceteroshisan.Eiridensaliquamnam,infugitnihilpri.Zzrilscaevola
ocurrereteteos,saleomnesconstituamcumea.Cuquisumosolet
contentiones,haseruditisanctusexplicariid,videutamurnominavitenec.
SHORTESTINDEPCLAIMX.Loremipsumideumdicoverituspertinacia,pri
idputantdolores.Eteamobliquedolores,idomnisillumest.Tamquam

PatentValuationReportbyValueMyPatent.com Page4
 definiebasduout.Iusanadhucgraecisoffendit,seaadhucputentcu,ut
vitaehonestatisphilosophiapri.Siteavitaealienum,utsedhinctantas
molestiae.Principespertinaciaconclusionemqueeaper,incommune
evertiturconsequateam.Cumollisconsulatuduo,totaantiopamanius.
Hasteullumprincipes.Etametelitrquo,seaveniamocurreretposidonium
cu.Anhomeroveritushas,adusuaperiamnominavi.Namteeuismod
delenitisingulis,aniusepicuripetentium.Dictasancillaeinteressetnamin,
deleniticonvenireuteum,summotibiqueperpetuaiuset.

Citations

ForwardCitations: 6
FwdCit.AveragePerYear: 1.74
FwdCit.Max/Year: 6
ForwardCitationsPatent#s: 78XXXXX;78XXXXX;77XXXXX;76XXXXX;76XXXXX;75XXXXX;
BackwardCitations: 6
BackwardCitationsPatent#s: 69XXXXX;2001XXXXX;2002XXXXX;2003XXXXX;2005XXXXX;2006XXXXX;

ForwardCitationsCitationstoPatentU.S.7,XXX,XXX
NumberofForwardCitations: 6
Max.AnnualForwardCitations: 6

Thenumberofforwardcitationsforthispatentishigh.Thisaddssomevaluetothepatent.Aforwardcitationis
madewhenanewpatentapplicationcitesthispatentaspriorart,acknowledgingtheexistenceofthispatent,and
differentiatingthetwoinventions.Apatentwithalargenumberofforwardcitations,isgenerallyconsideredmore
valuablethanapatentwithveryfewforwardcitations.Thenumberofforwardcitationsishelpfulindetermining
value,butapatentwithalargenumberofforwardcitationswillhavelittlevalueiftheclaimsareweak.So,the
impactoftheforwardcitationsonvalueisnotassignificantastheimpactofthestrengthoftheclaims.

BackwardCitationsCitationsbyPatentU.S.7,XXX,XXX
NumberofBackwardCitations: 6

Thenumberofbackwardcitationsforthispatentishigh.Thisaddssomevaluetothepatent.Whenthispatent
wasfiled,priorartwasidentifiedbythepatentexaminersandbytheinventor.Thepatentwasdistinguishedfrom
thepriorart,asthepatentexaminerdeterminedthatthepriorartwasinsufficientlyclosetothisinventionto
renderitunpatentable.Asubstantialnumberofbackwardcitations,indicatesthattheinventorandtheexaminer
didsomeresearchtouncoverpriorartthatmightrenderthispatentinvalid.Eachbackwardcitationisdeemedto
haveasmallimpactonthevalueofthepatent,increasingthevalueslightly.Thisisafactortohelpassessthe
valueofthepatent,butthisisnotverysignificantintheoverallvaluation.

PatentValuationReportbyValueMyPatent.com Page5
CitationsTable

Patent#PTO Title(andlinktoGooglePatents) Assignee Issue/Pub FirstInventor

Link Date
7XXXXXX Vixexsimulviderer,utpossit Teusuerat 2May10 ForensibusReprimique.
delenititakimatasea. ullamcorper.
7XXXXXX Loremipsumseakasdutroque Similique 12Jun09 FacilisiModeratius.
ei.Seaalienumoportere moderatius.
periculisei.
7XXXXXX Vixinillumrectequeintellegat, Quaequemaiorum. 2Apr08 MandamusOmittantur.
utevertideniquevel,visessent
obliqueet.Vidererefficiantur
cuqui.
7XXXXXX Novisadhucalterumfierent, Ansedprobo 8Mar07 TimeamSuscipiantur
hisuttationplatonem ancillae,
consequat.
7XXXXXX Vixexsimulviderer,utpossit Teusuerat 2Feb06 ProboAncillae
delenititakimatasea. ullamcorper.

7XXXXXX Loremipsumseakasdutroque Teusuerat 12Dec05 Populopartiendo.

ei.Seaalienumoportere ullamcorper.
periculisei.
7XXXXXX Vixinillumrectequeintellegat, Teusuerat 23Nov04 Forensibusreprimique.
utevertideniquevel,visessent ullamcorper.
obliqueet.Vidererefficiantur
cuqui.
7XXXXXX Novisadhucalterumfierent, Constituam 21Oct03 Forensibusreprimique.
hisuttationplatonem delicatissim
consequat.
7XXXXXX Vixexsimulviderer,utpossit Teusuerat 30Apr03 Constituamdelicatissim
delenititakimatasea. ullamcorper.
7XXXXXX Vixexsimulviderer,utpossit Populopartiendo. 22Feb02 Forensibusreprimique.
delenititakimatasea.

PatentValuationReportbyValueMyPatent.com Page6
CitationsGraph

2.5

2
Name of Assignee.
Name of Assignee
Name of Assignee.
Name of Assignee
1.5
Name of Assignee
Name of Assignee
Name of Assignee
Unknown

0.5

0
2002 2003 2005 2006 2009 2010

AgeofPatentU.S.7,XXX,XXX
DateofFiling: 12Month20XX
YearsUntilExpiration: 14.08

Thisparticularpatentisnotyetapproachingitsexpirationdate.Asageneralrule,whenthepatenthasexpired,or
determinedinvalid,itsvalueisreducedtozero.Assertingapatentagainstaninfringercantakeseveralyears,asa
resultoftheslowspeedatwhichthecasesproceedthroughcourt.So,asapatentapproachesthefinalfewyears
beforeexpiration,itsvaluefallssignificantly.

RelativeAgeofPatentU.S.7,XXX,XXX
RelativeAge: 0.17

Thispatentwasnotearlytothefield,butitwasnotlate.Thepatentwasfiledwhenbroadclaimsweredifficultto
haveallowedbythepatentofficeexaminers.Apatentfiledearlyinafieldoftechnologycanhavebroaderclaims
andmorevaluethanapatentfiledlater.Likealandgrabinrealestate,astimeproceedsandmorepatentsare
issuedwithinafield,thenewpatentsessentiallyfillthegapsleftbytheearlierpatents.Apatentfiledearlyinthe
fieldwillgenerallyhavebroaderclaimsthatalaterfiledpatent,andhencehasahighervalue.

PatentValuationReportbyValueMyPatent.com Page7
FamilyofInternationalCounterpartsforPatentU.S.7,XXX,XXX

NumberofInternationalFamily 0
Members:
InternationalCounterparts: None

ThispatentdoesnothavesufficientinternationalcounterpartstoaddvaluetotheU.S.patent.Patentsare
countryspecific.AU.S.patentcanbeassertedonlyinrelationtotheU.S.market.Internationalcounterpartssold
together,canaddvaluetoaU.S.patent.So,aU.S.patentwithcounterpartsinmajorcountriesisconsideredmore
valuablethanaU.S.patentwithoutinternationalcounterparts.

FamilyofU.S.ChildPatentsandApplicationsforPatentU.S.7,XXX,XXX

NumberofFamilyMembers: 1
FamilyMembers: US200X/01XXXXXA1;Jan 12,200X

ThispatenthassomefamilymembersintermsofrelatedU.S.patentsandcontinuationapplications,butthe
numberisnotsignificant.Patentssoldinlogicalportfoliosaremorevaluablethanindividualpatents,asthechance
ofinvalidationofasinglepatentismuchhigherthanthechanceofinvalidationforaportfoliocontaining
numerousrelatedpatents.Apatentwithchildapplications,partofalargerfamilywillbeconsideredmore
valuablethanapatentstandingalone.Ifthepatentissoldwithopencontinuations,childpatentapplicationswith
claimsthatcanbemoldedbytheacquirer,thevalueofthepatentwillbeenhanced.

FiguresandDefinitionsinPatentU.S.7,XXX,XXX
NumberofFigures: 5

Thispatentfeaturesanaveragenumberofdrawingstohelpdescribetheinvention.Inordertoavoidadisputeas
tothemeaningofawordintheclaims,itisgoodpracticeforeachwordintheclaimtobedescribedanddefinedin
thespecifications.Ifeachofthekeywordsisdefined,thiswilladdsomevaluetothepatent,ifallthekeywords
arenotdefined,thiswouldenhancethepossibilityoftheclaimmeaningbeingdisputedbyapotentialinfringer
andreducethevalueofthepatent.

Drawingsandotherfigurescanhelpexplainelementsofthepatentedinvention,helpclarifythemeaningofthe
claimsandcanaffectvaluation.Theeffectonvaluationnotsignificant,butapatentwithnumerousfigureswillbe
worthslightlymorethanifnofigureswereprovided.

ValueandSellability
Aspatentsareallunique,thenumberofpotentialbuyersforaparticularpatentcanbeveryfew,andfindingthe
matchingbuyercantakesometime.Basedonpatenttradingactivityinthissector,thechanceofsellingthis
patentfollowinga9monthperiodofmarketingbyaprofessionalpatentbrokerisestimatedtobe40%.

LicensestothePatent
Thevaluationprovidedinthisreportassumesthepatenthasnotbeenlicensed.Ifthepatenthasbeenlicensed,
thearoyaltystreamwillbecollectablebythebuyer,pleaseletusknowofthelicensingarrangement,asan

PatentValuationReportbyValueMyPatent.com Page8
alternativeformofvaluationcanbeusedtovaluethepatentinthissituation.Suchvaluationwillbebasedonthe
netpresentvalueofthefutureroyaltiesthepatentwillgenerate.

Ifthepatenthasbeenlicensed,andtherearenoroyaltiescollectablebyabuyer,thevalueofthepatentcanbe
significantlyreduced.Thevaluationhereassumestherearenolicenses,liensorencumbrancesaffectingcleantitle
tothepatents.

Ifevidenceofuseofthepatenthasbeencollected,identifyingthepotentialinfringers,andassessingthepotential
royaltiesthatmightbeawardedbyacourtinapatentlitigationprogram,pleaseletusknow,asanalternative
formofvaluationcanbeusedinthissituation.Suchvaluationwillbedeterminedbycalculatingthepotential
recoveryfromalicensingandassertionprogram.

PatentValuationNotBusinessValuation
Thisvaluationappliestothepatentyouprovidedforevaluation.Ifthepatentisacomponentofabusinessselling
productsthatincorporatethepatentedinvention,thenthebusinessshouldbevaluedseparatelybasedon
commonlyacceptedbusinessandcashflowvaluationmethodologies.Themostaccurateaggregatevaluation
estimateisachievedbyestimatingthevalueofthebusiness,withoutconsideringthepatents,thenestimatethe
valueofthepatents,withoutconsideringthevalueofthebusiness,thenaddingthevalueofthepatentstothe
valueofthebusiness.Thepatentisarighttoexcludeothersfromusingthepatentedinvention,andthepatents
valueisdrivenbytheabilitytoextractroyaltiesfrominfringers,sothevalueofthepatentisdeterminedbylooking
outsidethecompanyowningthepatentlookingattheactivitiesofcompetitors.So,thevalueofthepatentcan,
andshould,beseparatedfromthevalueofthebusinessowningthepatentifarealisticvalueistobedetermined.
Foradescriptionofcommonbusinessvaluationmethodologies,werecommendyouviewthefollowingslideshow
presentation:http://www.svbs.co/Public/SampleLecture/index.aspx.

NotesontheEffectsofPatentExpiration
Whenapatentexpires,onaccountofnonpaymentofmaintenancefees,orforanotherreason,thepatentis
invalidandhasnovalueatall.Sothevalueattachedtoapatentcanevaporatethemomentthepatentexpiresor
isinvalidatedbythecourtorbythepatentofficeexaminers.Someconsiderpatentstobesomewhatfragileassets
duetothefactthatthevaluecanevaporateentirelyuponthepatentsexpirationorinvalidation.

PatentValuationReportbyValueMyPatent.com Page9